Eligo Bioscience
Series AFranceSep 2017
Eligo Bioscience raised €17M in a Series A round in Sep 2017. The company is based in France. Investors in the round: Khosla Ventures, Seventure Partners. Data as of Nov 2026.
Amount raised
€17M
€16,739,203
Native amount
20,000,000 USD
Stage
Series A
series a
Investors
2
Provenance & confidence
High confidenceAmount
20,000,000 USD
ECB-at-date → €17M · rate 1.1948 on 2017-09-18
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
2 namedDate
Sep 2017
Round type
series a
Amount (EUR)
€17M